anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.07.19 | Novartis Hold | HSBC | |
| 19.07.19 | Roche buy | Goldman Sachs Group Inc. | |
| 19.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 19.07.19 | Novartis Neutral | Credit Suisse Group | |
| 19.07.19 | Novartis Hold | Deutsche Bank AG | |
| 19.07.19 | Novartis Underweight | Barclays Capital | |
| 18.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.07.19 | Novartis Neutral | UBS AG | |
| 18.07.19 | Novartis Neutral | UBS AG | |
| 18.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 16.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 15.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 11.07.19 | Roche buy | Goldman Sachs Group Inc. | |
| 08.07.19 | Roche buy | Deutsche Bank AG | |
| 08.07.19 | Novartis Hold | Deutsche Bank AG | |
| 05.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 01.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 28.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 27.06.19 | Novartis Neutral | UBS AG | |
| 25.06.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.06.19 | Roche buy | Deutsche Bank AG | |
| 14.06.19 | Alcon Neutral | BTIG Research | |
| 12.06.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 12.06.19 | Roche buy | Goldman Sachs Group Inc. | |
| 05.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 04.06.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.06.19 | Novartis Neutral | UBS AG | |
| 03.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 30.05.19 | Novartis Underweight | Morgan Stanley | |
| 29.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 29.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.05.19 | Novartis Neutral | Credit Suisse Group | |
| 28.05.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 27.05.19 | Novartis Neutral | UBS AG | |
| 27.05.19 | Novartis Hold | Deutsche Bank AG | |
| 24.05.19 | Novartis Neutral | UBS AG | |
| 24.05.19 | Novartis Underweight | JP Morgan Chase & Co. |